Pf HRP2 and Pf LDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria
Open Access
- 7 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 8 (1), 211-8
- https://doi.org/10.1186/1475-2875-8-211
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Update on Rapid Diagnostic Testing for MalariaClinical Microbiology Reviews, 2008
- Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenaseMalaria Journal, 2007
- Paracheck-Pf® accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis?Malaria Journal, 2007
- Ensuring quality and access for malaria diagnosis: how can it be achieved?Nature Reviews Microbiology, 2006
- Genetic Diversity ofPlasmodium falciparumHistidine‐Rich Protein 2 (PfHRP2) and Its Effect on the Performance of PfHRP2‐Based Rapid Diagnostic TestsThe Journal of Infectious Diseases, 2005
- The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria.Fundamental & Clinical Pharmacology, 2003
- Short report: Field evaluation of posttreatment sensitivity for monitoring parasite clearance of Plasmodium falciparum malaria by use of the Determine Malaria pf test in central India.The American Journal of Tropical Medicine and Hygiene, 2002
- Rapid Diagnostic Tests for Malaria ParasitesClinical Microbiology Reviews, 2002
- Plasmodium falciparum: Histidine-Rich Protein II Is Expressed during Gametocyte DevelopmentExperimental Parasitology, 2000
- Lactate Dehydrogenase and the Diagnosis of MalariaParasitology Today, 1998